JNM Global

Global Approval Partner

전체 글 2725

Korea MFDS, Notice Regarding Partial Amendment to the Regulations on the Review of Functional Cosmetics

On November 10, 2026, the Ministry of Food and Drug Safety (MFDS) of South Korea has issued an amendment to the regulations on the review of functional cosmetics. The revisions include the addition of *in vitro* test data—conducted according to methods recognized by organizations such as the International Organization for Standardization (ISO)—as supporting evidence for establishing sun protecti..

JNM Global/Cosmetic 2026.11.16

Thailand Thai FDA, Reduction of the review period for change notifications through approval by reference coun-tries

On October 21, 2026, the Thai Food and Drug Administration (Thai FDA) introduced a new processing timeline for medical device change notification. If a manufacturer can show that the same change has already been approved in a reference country, Thai FDA will process the application in 15 to 35 business days and external expert review is not required, regardless of whether the change is major or ..

Indonesia BPOM, Release Draft Regulation on Class B Cosmetic Production Scope

On November 2, 2026, the National Agency for Drug and Food Control of Indonesia(BPOM) has released a draft regulation concerning the types of cosmetic products that can be manufactured by Class B cosmetic manufacturers. The draft will replace the existing Regulation No. 8 of 2021 of BPOM on the Dosage Forms and Preparation Types of Certain Cosmetics That Can Be Produced by Cosmetic Manufacturers..

JNM Global/Cosmetic 2026.11.09

Korea MFDS, Revision of Guidelines for Cybersecurity Authorization and Review of Medical Devices

On October 30, 2026, the Ministry of Food and Drug Safety (MFDS) of South Korea has revised its "Guideline on Cybersecurity for Medical Devices" to align requirements for authentication information and passwords with international regulatory standards, while also providing more specific details on items frequently flagged during the review process. The details are as follow:- Ensure that authent..

Korea MFDS, Preparation of a Revised Guideline for Submitting Reports on Functional Cosmetics Exempt from Review

On October 22, 2026, the Ministry of Food and Drug Safety (MFDS) of South Korea has prepared a revised draft of the "Guidelines for Submitting Reports on Functional Cosmetics Exempt from Review," which includes guidance on verifying requirements when preparing such reports, as well as improvements to the reporting system for customized cosmetics. This draft revision mainly adds an explanation of..

JNM Global/Cosmetic 2026.11.02

Korea MFDS, Administrative Notice of a Proposed Partial Amendment to the Regulation on the Approval, Notifi-cation, and Review of In Vitro Diagnostic Medical Devices

On October 29, 2026, the Ministry of Food and Drug Safety (MFDS) of South Korea has announced a proposed amendment to the *Regulations on the Approval, Notification, and Review of In Vitro Diagnostic Medical Devices*. The objective of this amendment is to improve and rationalize the approval and review system for in vitro diagnostic (IVD) medical devices. Key changes include: (1) allowing clinic..

China NMPA, Announcement of Amendments Regarding the Implementation of Cosmetic Safety and Technical Standards

On October 8, 2026, China’s National Medical Products Administration (NMPA) has issued an amendment to the announcement regarding the implementation of safety and technical standards for cosmetic products. The key changes are as follows:1. Revisions regarding prohibited, restricted, and permitted ingredients- For products registered or submitted prior to these revisions, if adjustments to the fo..

JNM Global/Cosmetic 2026.10.26

Philippines PFDA, Proposal for the Adoption of Good Manufacturing Practice (GMP) Guidelines for Medical De-vices in Accordance with the National Standard (PNS) ISO 13485

On October 12, 2026, the Philippine Food and Drug Administration (FDA) has proposed a draft circular to adopt Good Manufacturing Practice (GMP) guidelines for medical devices, in accordance with the Philippine National Standard (PNS) ISO 13485:2019. The draft circular applies to all local manufacturers of medical devices—including in vitro diagnostic (IVD) medical devices—and also encompasses ot..

Brazil ANVISA, Brazil ANVISA: Draft Regulation on the Classification and Registration of Single-Use and Reusable Medical Devices

On September 24, 2026, the Brazilian National Health Surveillance Agency (ANVISA) proposed Public Consultation No. 1423 regarding the classification and registration of single-use and reusable medical devices. The purpose of this proposal is to establish new regulations setting forth the requirements for classifying and registering medical devices as single-use or reusable, including labeling an..